HIV & Viral Hepatitis Screening

CBH recommends that members seeking substance use disorder services be informed of available human immunodeficiency virus (HIV) and viral hepatitis services.

As of July 1, 2023, the Department of Drug and Alcohol (DDAP) requires that Single County Authorities and licensed drug and alcohol treatment centers provide HIV and viral hepatitis prevention/care services via integration or collaboration with other provider networks. The direct requirement can be found in Part V (V.8 & V.9; pp 23-24) and Appendix C (pp 46-47) of the Case Management and Clinical Services guide.

Below are tools and resources to support the implementation of these requirements.

Member Resources

The Philadelphia Department of Public Health provides HIV and viral hepatitis resources and education through prevention programs, testing, and treatment support. To learn more, visit phillykeeponloving.com.

Provider Resources

Testing Recommendations for People Who Use/Inject Drugs

To increase the identification and treatment of all people with HIV and viral hepatitis, the Centers for Disease Control and Prevention recommends that all adults receive HIV, Hepatitis B, and Hepatitis C testing at least once in their lifetime or more often as needed.

See below for specific testing recommendations. CBH has also prepared a testing worksheet for Providers.

Hepatitis A
  • The Advisory Committee on Immunization Practices recommends hepatitis A vaccination for unvaccinated adults at increased risk for infection or severe disease from infection.
  • The Hepatitis A vaccine series is typically administered over the course of 6 months.
Hepatitis B
  • The Advisory Committee on Immunization Practices recommends universal screening for all adults aged 18 years or older, at least once during their lifetime.
  • Routine periodic hepatitis B testing is suggested for people who inject drugs,
  • Clients without hepatitis B immunity, including adults aged 19–59 and adults 60 and older with risk factors, should be vaccinated.
  • Hepatitis B vaccination series is typically administered in 2-3 doses, depending on the vaccine.
Hepatitis C
  • Individuals over the age of 18, regardless of risk, should be tested at least once in their lifetime.
  • People who currently inject drugs and share needles, syringes, or other drug preparation equipment should receive routine periodic hepatitis C testing.
HIV
  • For people who share needles, syringes, or other drug injection equipment, or engage in transactional sex, HIV testing should be conducted at least once a year.
  • Due to an ongoing HIV outbreak in Philadelphia in people who inject drugs, the Philadelphia Department of Public Health recommends repeat HIV testing every 3 months in this population.
Testing Codes
Infection Laboratory Test Names Lab Test Codes (Quest) Lab Test Codes (LabCorp) Lab CPT Codes (ADL)
Hepatitis B Virus HBV Surface Antigen 498 006510 87340
Hepatitis B Virus HBV Surface Antibody 498 006395 86706
Hepatitis B Virus HBV Core Antibody 501 006718 86704
Hepatitis B Virus HBV Core IgM 4848 016881 86705
Hepatitis B Virus HBV DNA Quantitative 8369 551745 87517
Hepatitis C Virus HCV Antibody w/ Reflex to RNA 8472 144050 86803
HIV HIV 1, 2 Screening (Fourth Gen) 91431 083935 87389

Additional Resources for Providers

Viral Hepatitis

Philadelphia Community & Provider Resources

  • Phillyhepatitits.org – Philadelphia-specific resources for Hepatitis education and prevention from the City of Philadelphia Department of Public Health
  • Hepatitis C Allies of Philadelphia – Community toolkits, printable resources, and provider guidelines and trainings from the Health Federation of Philadelphia.

Guidelines and Information

Professional Organizations

HIV

Training Resources  

Guidelines 

 

CBH Providers: Stay up to date by signing up for our News Blast